VOLV.A

272.8

+0.59%↑

ASSA.B

321.9

0%↓

SEB.A

171.8

0%↓

SAAB.B

534.3

+1.77%↑

LIFCO.B

345.4

+0.58%↑

VOLV.A

272.8

+0.59%↑

ASSA.B

321.9

0%↓

SEB.A

171.8

0%↓

SAAB.B

534.3

+1.77%↑

LIFCO.B

345.4

+0.58%↑

VOLV.A

272.8

+0.59%↑

ASSA.B

321.9

0%↓

SEB.A

171.8

0%↓

SAAB.B

534.3

+1.77%↑

LIFCO.B

345.4

+0.58%↑

VOLV.A

272.8

+0.59%↑

ASSA.B

321.9

0%↓

SEB.A

171.8

0%↓

SAAB.B

534.3

+1.77%↑

LIFCO.B

345.4

+0.58%↑

VOLV.A

272.8

+0.59%↑

ASSA.B

321.9

0%↓

SEB.A

171.8

0%↓

SAAB.B

534.3

+1.77%↑

LIFCO.B

345.4

+0.58%↑

Search

Beijer Ref AB

Suletud

165.9 0.39

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

165.4

Max

167.65

Põhinäitajad

By Trading Economics

Sissetulek

1.2B

2B

Müük

1.3B

10B

P/E

Sektori keskmine

35.953

42.612

Aktsiakasum

1.56

Dividenditootlus

0.84

Kasumimarginaal

19.281

Töötajad

6,757

EBITDA

24M

1B

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.84%

2.27%

Järgmine tulemuste avaldamine

24. okt 2025

Turustatistika

By TradingEconomics

Turukapital

-862M

80B

Eelmine avamishind

165.51

Eelmine sulgemishind

165.9

Beijer Ref AB Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. aug 2025, 21:42 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4. aug 2025, 21:21 UTC

Tulu
Suurimad hinnamuutused turgudel

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4. aug 2025, 20:45 UTC

Tulu

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4. aug 2025, 19:15 UTC

Suurimad hinnamuutused turgudel

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4. aug 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. aug 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4. aug 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4. aug 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4. aug 2025, 21:30 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 21:21 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4. aug 2025, 21:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss $938M >RIG

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss/Shr $1.06 >RIG

4. aug 2025, 20:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4. aug 2025, 20:15 UTC

Tulu

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4. aug 2025, 20:13 UTC

Tulu

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4. aug 2025, 20:09 UTC

Tulu

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4. aug 2025, 20:06 UTC

Tulu

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4. aug 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4. aug 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4. aug 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4. aug 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Beijer Ref AB Prognoos

Finantsandmed

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Beijer Ref AB

Beijer Ref AB (publ), together with its subsidiaries, provides refrigeration, air conditioning, and heating solutions worldwide. It operates through three segments: Commercial and Industrial Refrigeration, Heating, Ventilation, and Air Conditioning (HVAC), and Original Equipment Manufacturer (OEM). The company primarily offers cooling components, air conditioning units, and heat pumps. In addition, it provides commercial refrigeration, which are used in shops, catering, cafes, hotels, and smaller refrigerated warehouses; and central refrigeration systems including freezer and refrigeration plants in modern food retailing, and industrial refrigeration, such as refrigeration plants for ice rinks, food manufacturing, and offshore industries. The company also offers HVAC or comfort cooling products, and air-water heat pumps for climate control and ventilation for homes, offices and shops; and manufacture refrigeration plants and heat pumps primarily based on natural refrigerants, such as CO2, ammonia, and propane. It distributes its products through its branch network and logistics centres across Nordic countries, Central Europe, Southern Europe, Eastern Europe, Africa, and the Asia Pacific. The company was formerly known as G & L Beijer AB (publ) and changed its name to Beijer Ref AB (publ) in 2014. Beijer Ref AB (publ) was founded in 1866 and is headquartered in Malmö, Sweden.